Covid 19 Drug Phase 3 DATA in Q4 = Next 10++BAGGER
Post# of 74
CTIC = Market Cap $103 Million / Cash $81 Million
CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial
https://finance.yahoo.com/news/cti-biopharma-...00668.html
- Company Expects to Report Topline Data by the End of 2020 -